Synthesis,Characterization, and Reactivity of a Uranium(VI) Carbene Imido Oxo Complex

We report the uranium(VI) carbene imido oxo complex [U(BIPM^TMS)(NMes)(O)(DMAP)₂] ( 5 , BIPM^TMS=C(PPh₂NSiMe₃)₂; Mes=2,4,6‐Me₃C₆H₂; DMAP=4‐(dimethylamino)pyridine) which exhibits the unprecedented arrangement of three formal multiply bonded ligands to one metal center where the coordinated heteroatoms derive from different element groups. This complex was prepared by incorporation of carbene, imido, and then oxo groups at the uranium center by salt elimination, protonolysis, and two‐electron oxidation, respectively. The oxo and imido groups adopt axial positions in a T‐shaped motif with respect to the carbene, which is consistent with an inverse trans‐influence. Complex 5 reacts with tert‐butylisocyanate at the imido rather than carbene group to afford the uranyl(VI) carbene complex [U(BIPM^TMS)(O)₂(DMAP)₂] ( 6 ).     

Two‐Electron Reductive Carbonylation of Terminal Uranium(V) and Uranium(VI) Nitrides to Cyanate by Carbon Monoxide

Two‐electron reductive carbonylation of the uranium(VI) nitride [U(Tren^TIPS)(N)] ( 2 , Tren^TIPS=N(CH₂CH₂NSiiPr₃)₃) with CO gave the uranium(IV) cyanate [U(Tren^TIPS)(NCO)] ( 3 ). KC₈ reduction of 3 resulted in cyanate dissociation to give [U(Tren^TIPS)] ( 4 ) and KNCO, or cyanate retention in [U(Tren^TIPS)(NCO)][K(B15C5)₂] ( 5 , B15C5=benzo‐15‐crown‐5 ether) with B15C5. Complexes 5 and 4 and KNCO were also prepared from CO and the uranium(V) nitride [{U(Tren^TIPS)(N)K}₂] ( 6 ), with or without B15C5, respectively. Complex 5 can be prepared directly from CO and [U(Tren^TIPS)(N)][K(B15C5)₂] ( 7 ). Notably, 7 reacts with CO much faster than 2 . This unprecedented f‐block reactivity was modeled theoretically, revealing nucleophilic attack of the π* orbital of CO by the nitride with activation energy barriers of 24.7 and 11.3 kcal mol^?1 for uranium(VI) and uranium(V), respectively. A remarkably simple two‐step, two‐electron cycle for the conversion of azide to nitride to cyanate using 4 , NaN₃ and CO is presented.     

The Nature of the UC Double Bond: Pushing the Stability of High‐Oxidation‐State Uranium Carbenes to the Limit

Treatment of [K(BIPM^MesH)] (BIPM^Mes={C(PPh₂NMes)₂}^2?; Mes=C₆H₂‐2,4,6‐Me₃) with [UCl₄(thf)₃] (1 equiv) afforded [U(BIPM^MesH)(Cl)₃(thf)] ( 1 ), which generated [U(BIPM^Mes)(Cl)₂(thf)₂] ( 2 ), following treatment with benzyl potassium. Attempts to oxidise 2 resulted in intractable mixtures, ligand scrambling to give [U(BIPM^Mes)₂] or the formation of [U(BIPM^MesH)(O)₂(Cl)(thf)] ( 3 ). The complex [U(BIPM^Dipp)(μ‐Cl)₄(Li)₂(OEt₂)(tmeda)] ( 4 ) (BIPM^Dipp={C(PPh₂NDipp)₂}^2?; Dipp=C₆H₃‐2,6‐iPr₂; tmeda=N,N,N′,N′‐tetramethylethylenediamine) was prepared from [Li₂(BIPM^Dipp)(tmeda)] and [UCl₄(thf)₃] and, following reflux in toluene, could be isolated as [U(BIPM^Dipp)(Cl)₂(thf)₂] ( 5 ). Treatment of 4 with iodine (0.5 equiv) afforded [U(BIPM^Dipp)(Cl)₂(μ‐Cl)₂(Li)(thf)₂] ( 6 ). Complex 6 resists oxidation, and treating 4 or 5 with N‐oxides gives [{U(BIPM^DippH)(O)₂‐ (μ‐Cl)₂Li(tmeda)] ( 7 ) and [{U(BIPM^DippH)(O)₂(μ‐Cl)}₂] ( 8 ). Treatment of 4 with tBuOLi (3 equiv) and I₂ (1 equiv) gives [U(BIPM^Dipp)(OtBu)₃(I)] ( 9 ), which represents an exceptionally rare example of a crystallographically authenticated uranium(VI)–carbon σ bond. Although 9 appears sterically saturated, it decomposes over time to give [U(BIPM^Dipp)(OtBu)₃]. Complex 4 reacts with PhCOtBu and Ph₂CO to form [U(BIPM^Dipp)(μ‐Cl)₄(Li)₂(tmeda)(OCPhtBu)] ( 10 ) and [U(BIPM^Dipp)(Cl)(μ‐Cl)₂(Li)(tmeda)(OCPh₂)] ( 11 ). In contrast, complex 5 does not react with PhCOtBu and Ph₂CO, which we attribute to steric blocking. However, complexes 5 and 6 react with PhCHO to afford (DippNPPh₂)₂C?C(H)Ph ( 12 ). Complex 9 does not react with PhCOtBu, Ph₂CO or PhCHO; this is attributed to steric blocking. Theoretical calculations have enabled a qualitative bracketing of the extent of covalency in early‐metal carbenes as a function of metal, oxidation state and the number of phosphanyl substituents, revealing modest covalent contributions to U?C double bonds.     

Lanthanide discs chill well and relax slowly

The synthesis, structure and magnetic properties of two isostructural heptametallic lanthanide discs are reported, showing single molecule magnet (SMM) behaviour with a large energy barrier for the dysprosium analogue and a large magnetocaloric effect (MCE) for the gadolinium analogue.     

Rapid aqueous ‘click chemistry’ using Cu(I)-loaded dendrimers as macromolecular catalysts

Here, we investigate the catalytic activity of various copper (Cu)-loaded poly(amido amine) (PAMAM) dendrimers towards the Cu(I)-catalysed azide-alkyne cycloaddition (CuAAC). Reactivity is tested on a model reaction between azido propanol and propargyl alcohol in aqueous solution. We observe significantly faster conversion using PAMAM dendrimers as macromolecular Cu(I) ligands compared to traditional small molecular ligand systems, and demonstrate that the macromolecular catalyst can be removed by ultrafiltration.     

Structural and magnetic studies of the tris(cyclopentadienyl)manganese(II) "paddle-wheel" anions [Cp(3-n)(MeCp)(n)Mn](-) (n=0-3, MeCp=C(5)H(4)CH(3), Cp=C(5)H(5))

The ion-contact complexes [{(eta(5)-Cp)(2)Mn(eta(2):eta(5)-Cp)K}(3)]x0.5 THF (1x0.5 THF) and [{(eta(2)-Cp)(2)(eta(2);eta(5)-MeCp)MnK(thf)}]x2 THF (2x2 THF) and ion-separated complexes [Mg(thf)(6)][(eta(2)-Cp)(3)Mn](2) (3), [Mg(thf)(6)][(eta(2)-Cp)(eta(2)-MeCp)(2)Mn)](2)x0.5 THF (4x0.5 THF), [Mg(thf)(6)][(eta(2)-MeCp)(3)Mn)](2)x0.5 THF (5x0.5 THF) and [Li([12]crown-4)](5)[(eta-Cp)(3)Mn](5) (6) (Cp=C(5)H(5), CpMe=C(5)H(4)CH(3)), have been prepared and structurally characterised. The effects of varying the Cp and CpMe ligands in complexes 1-5 have been probed by variable-temperature magnetic susceptibility measurements and EPR spectroscopic studies.     

Survival of antarctic soil metazoans at -80 degree C for six years

A sample of the liverwort Cephaloziella varians was collected on 1 January 1999 at Rothera Point on the Wright Peninsula, Adelaide Island, western Antarctic Peninsula and was partially dried and then frozen at -80 degree C. The sample was rapidly defrosted to c. 10 degree C after six years and two months of storage at this temperature. Nematodes, tardigrades and a bdelloid rotifer present in the sample were found to have survived. Of the 159 nematodes recovered from the sample, 49 (31%) were alive: of the tardigrades and rotifers, two of 15 (13%) and one of 48 (2%) had survived, respectively. A Chi-square test showed that there was a significant association between nematode taxon and survival: a greater proportion of Coomansus gerlachei individuals were alive than of Rhyssocolpus paradoxus. A Chi-square test also showed that there was a significant association between phylum and survival: a significantly greater proportion of nematodes or tardigrades were alive than of bdelloid rotifers. We conclude that Antarctic soil metazoans are capable of surviving long-term exposure to low sub-zero temperatures and that there may be taxon-specific effects of freezing on survival.     

A Bivalent Inhibitor of Prostate Specific Membrane Antigen Radiolabeled with Copper‐64 with High Tumor Uptake and Retention

Molecules containing lysine‐ureido‐glutamate functional groups bind to the active site of prostate specific membrane antigen, which is overexpressed in prostate cancer. To prepare copper radiopharmaceuticals for the diagnosis and therapy of prostate cancer, macrobicyclic sarcophagine ligands tethered to either one or two lysine‐ureido‐glutamate functional groups through an appropriate linker have been prepared. Sarcophagine ligands can be readily radiolabeled with positron‐emitting copper‐64 at room temperature. The bivalent agent, in which two targeting groups are tethered to a single copper complex, dramatically outperforms the monomeric agent with respect to tumor uptake and retention. The high tumor uptake, low background, and prolonged tumor retention, even at 24 hours post injection, suggest the bivalent agent is a promising diagnostic for prostate cancer and could be used for prospective dosimetry for therapy with a copper‐67 variant.